<DOC>
	<DOCNO>NCT02558504</DOCNO>
	<brief_summary>First intent treatment superficial circular esophageal neoplasm surgical resection . Endoscopic mucosal resection recommend due high rate subsequent esophageal stenosis ( high 80 % ) . Surgical limit relate high level morbidity due , particular , respiratory complication infection require prolonged hospitalisation , significant rate mortality ( 2 5 % ) . As alternative surgical treatment , innovative technique remove esophageal circular preneoplastic neoplastic lesion develop : consists ablate mucosa mean balloon fix diameter incorporate approximately 100 electrode surface emit radiofrequency wave ( HALO® Radiofrequency Ablation Technology System ) . By vary strength duration electrical impulse , possible obtain homogenous control destruction tissue whole mucosa , leave remain pre-neoplastic neoplastic element underneath . The technique use high grade glandular epithelial neoplasia , Vienna 4-1 4-2 , develop mucosa risk , i.e . Barrett 's oesophagus , occupy half circumference esophagus require surgical treatment . The expected benefit patient link reduced invasiveness technique comparison surgery</brief_summary>
	<brief_title>Radiofrequency Treatment Barrett 's Oesophagus</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Age 18 year , General Condition WHO 0 , 1 2 , ASA Class I II , eligible endoscopic surgical treatment curative intent , Histological diagnosis high grade glandular epithelial neoplasia ( Vienna 41 446 ) , possibly multifocal stage 0 ( Tis , N0 , M0 ) , Endoscopic histological confirm diagnosis intestinal metaplasia , Histological diagnosis confirm two endoscopy biopsy two pathological reading ; biopsy carry accord protocol SFED ( fourquadrant biopsy every cm ) least acetic acid stain . Operators describe Barrett 's esophagus use SFED planimetric model . The final exam two month date treatment achieve investigator establishment , Extension height Barrett 's esophagus upstream upper part gastric fold palisade vessel : Minimum 1 cm , Maximum 12 cm . In case previous treatment mucosal resection submucosal dissection ( DSM ) severe dysplasia microinvasive carcinoma : resect lesion must well differentiate confine mucosa ( m2 maximum ) histological analysis , resection two month , resection must macroscopically complete laterally , resection must histologically complete depth , resection must histologically complete laterally regard microinvasive cancer , say clear margin safety ( margin may highgrade dysplasia provide latter macroscopic translation ) , At least one endoscopic histologic followup conduct dye period less two month date treatment , investigator establishment . Patient may take inhibitor proton pump equivalent 2 time 40 mg esomeprazole , No mediastinal celiac , suspect metastatic lymph node EUS , Affiliation social security system similar , Lack participation another clinical study , Informed consent sign . Aged 18 , Lack inform consent sign , Radiofrequency treatment history , go neoplastic history short prognosis , Concomitant participation another clinical study Contraindication general anesthesia , Patient esophageal location scleroderma Presence cardiac pacemaker stimulator Pregnant woman likely absence effective contraception , Esophageal stenosis prevent passage endoscope , Histology glandular neoplasia , History current history esophageal cancer invade submucosal layer esophagus , Surgical treatment history ( except antireflux treatment ) esophageal radiotherapy , previous esophageal treatment another method ablation : photodynamic therapy , argon plasma coagulation , laser , ... . Esophageal varix observe endoscopy , Coagulopathy take anticoagulant responsible INR &gt; 1.3 platelet count &lt; 75,000 per microL , Life expectancy le 3 year , due intercurrent disease , especially neoplastic , Severe Medical pathology : Liver cirrhosis ( ChildPugh stage ) Respiratory failure : VEMS ( Maximum Expiratory Volume Second ) &lt; 1L / min PaO2 &lt; 60 mmHg PaCO2 &gt; 45 mmHg Renal failure ( Cl Cr &lt; 60 mL /min /1,73m² ) , Heart attack within last six month progressive coronary artery disease , Severe distal arteriopathie &gt; stage II Leriche Fontaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>